웹2024년 3월 22일 · Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 2012; 379:315. Zhang XL, Shi HJ, Cui SZ, et al. Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative … 웹2024년 5월 29일 · Editorial Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621. …
Trastuzumab in combination with chemotherapy versus …
웹2024년 4월 12일 · Lancet 376:687–697 CrossRef Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. 웹The cardiovascular complications of cancer therapeutics are the focus of the burgeoning field of cardio-oncology. A common challenge in this field is the impact of cancer drugs on cardiac repolarization (ie, QT prolongation) and the potential risk re and fais
Effect of a Proposed Trastuzumab Biosimilar Compared …
웹Autor: Doc. MUDr. Milada Zemanová, Ph. D.Onkologická klinika, 1. lékařská fakulta University Karlovy v Praze a Všeobecná fakultní nemocnice v Praze V posledních dvaceti letech dochází v západním světě k významným změnám v epidemiologii karcinomů jícnu a žaludku. Zatímco incidence karcinomů těla a výtokové části žaludku významně klesá, dochází k až ... 웹41. Bang YJ, Kim YW, Yang HK, et al; CLASSIC trial investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315-321. 42. Noh SH, Park SR, Yang HK, et al; CLASSIC trial investigators. 웹2024년 10월 17일 · Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–21. pmid:22226517 . View Article PubMed/NCBI Google Scholar 17. how to spell wherever